Optimized Treatment Relieves Pain in Chronic Pancreatitis

Share this content:
Optimized Treatment Relieves Pain in Chronic Pancreatitis
Optimized Treatment Relieves Pain in Chronic Pancreatitis

TUESDAY, Jan. 10, 2017 (HealthDay News) -- For most patients with chronic pancreatitis (CP), optimized medical and interventional treatment is associated with significant pain relief, according to a study published online Jan. 4 in the Journal of Gastroenterology and Hepatology.

For the study, researchers from the All India Institute of Medical Sciences in New Delhi enrolled 313 consecutive patients with CP (92 percent with abdominal pain) who were treated with a well-balanced diet, pancreatic enzymes, and antioxidants. If medical therapy failed, patients were offered endoscopic therapy and/or surgery.

The researchers found that the etiology of CP was idiopathic in 71.6 percent of the patients and alcohol in 26.2 percent. Significant pain relief was achieved at one-year follow-up in 84.7 percent of patients: 52.1, 16.7, 7.6, and 8.3 percent, respectively, with medical therapy, endoscopic therapy, surgery, and spontaneously. There was a significant decrease in the mean pain score, from 6.36 ± 1.92 to 1.62 ± 2.1. Among the 261, 218, 112, and 51 patients with abdominal pain followed up for three, five, 10, and 15 years, 54, 57.3, 60.7, and 68.8 percent, respectively, became pain-free at follow-up.

"Significant pain relief is achieved in the majority of patients with optimized medical and interventional treatment," the authors write.

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »